Diagnostic Criteria for Diabetic Ketoacidosis (DKA)
DKA is diagnosed by the triad of hyperglycemia (blood glucose >250 mg/dL), metabolic acidosis (pH <7.3, serum bicarbonate <18 mEq/L), and elevated ketones in blood or urine. 1
Essential Diagnostic Criteria
- Blood glucose >250 mg/dL (though euglycemic DKA with glucose <250 mg/dL can occur, especially with SGLT2 inhibitor use) 1, 2
- Arterial pH <7.3 3, 1
- Serum bicarbonate <18 mEq/L 3, 1
- Positive serum and urine ketones 3, 1
- Elevated anion gap >10-12 mEq/L 3
- Mental status ranging from alert to coma depending on severity 3
Severity Classification
DKA can be classified into three severity levels based on arterial pH and serum bicarbonate 3:
Mild DKA:
- Arterial pH: 7.25-7.30
- Serum bicarbonate: 15-18 mEq/L
- Mental status: Alert 3
Moderate DKA:
- Arterial pH: 7.00-7.24
- Serum bicarbonate: 10 to <15 mEq/L
- Mental status: Alert/drowsy 3
Severe DKA:
- Arterial pH: <7.00
- Serum bicarbonate: <10 mEq/L
- Mental status: Stupor/coma 3
Laboratory Evaluation
Essential tests for confirming DKA diagnosis:
β-hydroxybutyrate measurement is preferred over nitroprusside-based ketone tests for diagnosis and monitoring of DKA, as nitroprusside methods do not measure β-hydroxybutyrate, which is the predominant ketone in DKA 3, 1
Clinical Presentation
- Common symptoms include polyuria, polydipsia, polyphagia, weight loss, vomiting, abdominal pain, dehydration, weakness, and altered mental status 3, 4
- Physical findings may include poor skin turgor, Kussmaul respirations (deep, rapid breathing), tachycardia, hypotension, and potentially altered mental status 3, 1
- DKA typically evolves rapidly (usually <24 hours) 3, 1
- Up to 25% of DKA patients may present with emesis, which can be coffee-ground in appearance due to hemorrhagic gastritis 3
Special Considerations
Euglycemic DKA: Blood glucose <250 mg/dL with ketoacidosis can occur with:
Differential diagnosis for high anion gap metabolic acidosis includes:
Common Precipitating Factors
- Infection (most common) 3, 1
- New-onset type 1 diabetes 3, 1
- Insulin omission or inadequate insulin dosing 3, 1
- Cerebrovascular accident 3, 1
- Myocardial infarction 3, 1
- Drug use (corticosteroids, thiazides, sympathomimetic agents) 3, 1
- Alcohol abuse 3, 1
- Pancreatitis 3, 1
Monitoring During Treatment
- β-hydroxybutyrate levels should be used to monitor treatment response rather than nitroprusside-based ketone tests 3, 1
- Resolution of acidosis or reduction in blood β-hydroxybutyrate is the marker for successful treatment 3, 1
- Blood ketone determinations that rely on the nitroprusside reaction should not be used to monitor treatment of DKA 3